ZYTHERA

Zythera is a specialty pharmaceutical company based in the Philippines that focuses on the commercialization and distribution of innovative therapies for rare diseases and specialized medical conditions. The company serves as a strategic partner for global biotechnology firms, providing end-to-end services including regulatory affairs, market access, and patient support programs. Zythera's portfolio primarily features enzyme replacement therapies for lysosomal storage disorders such as Gaucher disease, Fabry disease, and Pompe disease. By bridging the gap between global innovation and local patient needs, Zythera plays a critical role in the Philippine healthcare ecosystem for orphan diseases. The company is also active in oncology and hematology, aiming to bring life-saving treatments to patients with high unmet medical needs.